Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
137 hedge funds and large institutions have $843M invested in Amedisys in 2014 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 37 increasing their positions, 55 reducing their positions, and 15 closing their positions.
164% more call options, than puts
Call options by funds: $7.45M | Put options by funds: $2.82M
93% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 15
39% more capital invested
Capital invested by funds: $606M → $843M (+$237M)
10% more funds holding
Funds holding: 125 → 137 (+12)
33% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 55
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| 1 |
D.E. Shaw & Co
New York
|
+$10.5M |
| 2 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$7.49M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.99M |
| 4 |
Morgan Stanley
New York
|
+$2.79M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.84M |
Top Sellers
| 1 |
JCG
JHL Capital Group
Chicago,
Illinois
|
-$18.3M |
| 2 |
JP Morgan Chase
New York
|
-$10.8M |
| 3 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$10.1M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.97M |
| 5 |
Millennium Management
New York
|
-$2.68M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MFS
151
MSI Financial Services
Springfield,
Massachusetts
| – | -$1K | -54 | Closed |
|
152
SEI Investments
Oaks,
Pennsylvania
| – | +$49 | +2 | New |
|
AMED Hedge Fund Activity: Q4 2014 in Review
137 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q4 2014, worth a combined $843M — up 39% from $606M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new AMED positions and 15 closed out — a net gain of 14 holders — while 37 added to existing stakes and 55 trimmed.
The largest buyer was D.E. Shaw & Co, adding an estimated $10.5M. The largest seller was JHL Capital Group, exiting entirely with an estimated $18.3M sold.
- 137 institutional investors held Amedisys (AMED) as of Q4 2014, up from 125 in Q3 2014.
- Funds reported $843M of Amedisys stock for Q4 2014, up 39% quarter-over-quarter.
- 29 funds opened new Amedisys positions in Q4 2014 and 15 closed out, a net change of +14 holders.
- The largest Amedisys buyer in Q4 2014 was D.E. Shaw & Co, an estimated $10.5M added.
- The largest Amedisys seller in Q4 2014 was JHL Capital Group, an estimated $18.3M sold.
Based on aggregated 13F filings for Q4 2014.